Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Calquence Japan approval for treatment-nave CLL
Investegate announcements from AstraZeneca PLC, Calquence Japan approval for treatment-na�ve CLL
Stay updated with breaking news from Dave Fredrickson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from AstraZeneca PLC, Calquence Japan approval for treatment-na�ve CLL
AstraZeneca and MSD's Lynparza approved in the EU for prostate cancer
The FTSE 100 pharma giant said Imfinzi has been given the green light in the EU for the treatment of adult patients with biliary tract cancer in combination with chemotherapy.
EU patients with an advanced prostate cancer will benefit from a newly approved Lynparza-based treatment combination for the first time.
The FTSE 100 pharma giant said Imfinzi has been given the green light in the EU for the treatment of adult patients with biliary tract cancer in combination with chemotherapy.